AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Impact of Blood Biomarkers and Long-Term Outcomes in Amyloidosis
This chapter explores the impact of blood biomarkers on the outcomes of amyloidosis patients, emphasizing clone-related factors and the potential for deep responses to therapy. It also discusses the role of biomarkers in identifying patients at risk of relapse and questions the role of stem cell transplant in the era of DARA-based treatment.